Pharmaceutical Synthesis Pathways Utilizing O-Methylanisole Derivatives are pivotal intermediates in the development of various active pharmaceutical ingredients. These compounds, identified by their distinct CAS number, are represented by well-defined molecular data, including molecular formula, exact molecular weight, and a systematic IUPAC name that ensures precise chemical identification. For unequivocal reference, the InChIKey provides a standardized digital fingerprint, enabling seamless integration into digital databases and regulatory documents. Such derivatives of O-Methylanisole are frequently classified as vital intermediates or reagents, underpinning a wide array of synthesis routes in medicinal chemistry.
Regarding their physical and chemical characteristics, O-Methylanisole derivatives typically present defined specifications essential for process design and quality assurance. Key attributes such as melting point, boiling point, density, flash point, and vapor pressure delineate their handling and processing parameters. These characteristics are central to both laboratory-scale applications and industrial-scale pharmaceutical manufacturing, defining safe operation windows and informing best practices for synthetic route optimization.
Compliance with regulatory frameworks is an essential aspect of utilizing O-Methylanisole derivatives in pharmaceutical synthesis. According to the European Chemicals Agency (ECHA), the REACH registration status, including the assigned article number and corresponding tonnage band, confirms their authorized use and volume limits within the European Union. On a global scale, inclusion in the United States TSCA inventory under the appropriate section establishes compliance for supply within North America. Notably, alignment with ICH guidelines—citing the code and the precise revision, for example ICH Q3C(R8), which details solvent residue limits—guarantees the suitability of these intermediates for pharmaceutical-grade synthesis. When applicable, the GHS hazard classification communicates critical safety information, highlighting explicit H-phrases and any assigned signal word to direct proper handling measures. Where a pharmacopeia reference is stated, the relevant chapter ensures harmonization with compendial quality standards. Occupational exposure limits, such as OSHA PEL or NIOSH REL levels, are observed when specified, further safeguarding worker health during manufacturing and processing.
Within the pharmaceutical sector, O-Methylanisole derivatives play a strategic role as chemical intermediates in the synthesis pathways leading to diverse medicinal agents. Their reactivity and functional group compatibility are exploited in constructing complex heterocycles, introducing methoxy substituents, or enabling regioselective transformations integral to the preparation of APIs. The literature cites several use cases where these derivatives contribute to the synthesis of antihypertensive, anti-inflammatory, and central nervous system active compounds, supporting their recurring adoption in drug development projects and process scale-up environments.
Safeguarding the quality and stability of O-Methylanisole derivatives requires industry-standard packaging solutions. These substances are typically offered in 25-kilogram fiber or HDPE drums for development and kilo-scale use, as well as 200-kilogram drums or IBC containers for bulk applications. Stable storage conditions mandate a cool, well-ventilated, and dry environment, minimizing exposure to heat sources, acids, or oxidizing agents in line with GHS stability recommendations. Adhering to these recommendations protects both material integrity and operational safety. For this class of chemical intermediates, a typical shelf life under recommended storage conditions extends to two years, contingent on periodic verification of quality attributes.
For the most accurate and comprehensive information supporting the synthesis, quality control, and regulatory aspects of O-Methylanisole derivatives, reference is made to PubChem, NIST, ECHA, and the EPA TSCA Inventory. These resources consolidate primary data from trusted authorities and uphold best practices in sourcing high-quality chemical intermediates for pharmaceutical manufacturing.
Sources:
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/{cid}
NIST: https://webbook.nist.gov/cgi/cbook.cgi?Name={cas_number}
ECHA: {echa_url}
EPA TSCA: https://www.epa.gov/tsca-inventory
Related Articles
